Beijing Surgerii Completes A Round for Next-Gen Robotic Surgery Device

Published on: Feb 27, 2019
Author: Amy Liu

Beijing Surgerii Technology completed a Series A financing of “millions of RMB” led by Shunwei Capital, an early and mid-stage investor with a focus on the internet. Founded in 2014, Surgerii is developing a third-gen robotic surgery device based on continuum technology. Continuum technology requires only a single incision and provides a probe with flexible curvature, which allows the probe to follow the winding paths of blood vessels more easily.

Source: China Biotoday

Biotechnology Genomics Healthcare Services Life Science Medical Device Pharmaceutical